crystal structure of (s)-5-chloro-n-({2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide
Clicks: 290
ID: 169632
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
290 views
30 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #48 of 231 articles by views in Disability and rehabilitation
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 231 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The asymmetric unit of the crystal of the title compound (common name rivaroxaban), C19H18ClN3O5, contains two rivaroxaban molecules with different conformations; the C—C—N—C torsion angles between the oxazolidine and thiophene rings are −171.1 (7) and −106.8 (9)° in the two independent molecules. In the crystal, classical N—H...O hydrogen bonds and weak C—H...O hydrogen bonds link the molecules into a three-dimensional supramolecular architecture.
| Reference Key |
shen2018actacrystal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Jie Shen;Gu-Ping Tang;Xiu-Rong Hu |
| Journal | Disability and rehabilitation |
| Year | 2018 |
| DOI |
10.1107/S2056989017017819
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.